Ledger.Open graph →
SEC Form D · filed March 18, 2022

Sunshine Biopharma, Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
POINTE-CLAIRE, Quebec, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David N. Natan · POINTE-CLAIRE, Quebec, CanadaDirectorCamille N. Sebaaly · POINTE-CLAIRE, Quebec, CanadaExecAbderrazzak N. Merzouki · POINTE-CLAIRE, Quebec, CanadaExec · DirectorSteve N. Slilaty · Montreal, Quebec, CanadaExec · DirectorRabi N. Kiderchah · POINTE-CLAIRE, Quebec, CanadaDirectorAndrew N. Keller · POINTE-CLAIRE, Quebec, CanadaDirectorDavid N. Natan · POINTE-CLAIRE, Quebec, CanadaDirectorCamille N. Sebaaly · POINTE-CLAIRE, Quebec, CanadaExecAbderrazzak N. Merzouki · POINTE-CLAIRE, Quebec, CanadaExec · DirectorSteve N. Slilaty · POINTE-CLAIRE, Quebec, CanadaExec · DirectorRabi N. Kiderchah · POINTE-CLAIRE, Quebec, CanadaDirectorAndrew N. Keller · POINTE-CLAIRE, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗